Tenofovir Plus Didanosine as Nrti Backbone in HIV-Infected Subjects

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|23|2789-2793

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.23, 2006-10, pp. : 2789-2793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

By Morse G.D.  

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite

NRTI Backbone in HIV Treatment: Will it Remain Relevant?

By Tressler Randall  

Drugs, Vol. 72, Iss. 16, 2012-11 ,pp. : 2051-2062

Adis International

Access to resources Recommend Favorite

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

By Gazzard Brian G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 793-802

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis B Vaccination in HIV-Infected Subjects

By  

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-01 ,pp. : 191-194

Bentham Science Publishers

Access to resources Recommend Favorite

APOE ε4 allele and CSF APOE on Cognition in HIV-Infected Subjects

By Andres Marilou  

Journal of Neuroimmune Pharmacology, Vol. 6, Iss. 3, 2011-09 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite